Ailin Lepletier

7PUBLICATIONS
24CO-AUTHORS
AutoimmunityTumour immunologyInnate immunityMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 25, 2025
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease.

Rukshan Ahamed Mohamed Rafeek, Natkunam Ketheesan, Michael F Good

|Feb 28, 2024
Integrative temporal multi-omics reveals uncoupling of transcriptome and proteome during human T cell activation.

Harshi Weerakoon, Ahmed Mohamed, Yide Wong

|Sep 25, 2023
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.

Victoria Ozberk, Mehfuz Zaman, Ailin Lepletier

|Feb 04, 2023
Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model.

Simone Reynolds, Rukshan Ahamed Mohamed Rafeek, Adam Hamlin

|Sep 10, 2021
Expression of CD49f defines subsets of human regulatory T cells with divergent transcriptional landscape and function that correlate with ulcerative colitis disease activity.

Harshi Weerakoon, Jasmin Straube, Katie Lineburg

|Mar 18, 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2.

Manisha Pandey, Victoria Ozberk, Sharareh Eskandari

Pageof 2

Frequent Collaborators

4 joint publications

Manisha Pandey

3 joint publications

Harshi Weerakoon

3 joint publications

Michael F Good

2 joint publications

Michelle M Hill